4.5 Article

A multicenter, randomized, double-blind, placebo-controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 11 years, with an open-label extension

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

The Efficacy of Triptans in Childhood and Adolescence Migraine

Stefan Evers

CURRENT PAIN AND HEADACHE REPORTS (2013)

Article Pediatrics

Migraine Therapeutics in Adolescents

Haihao Sun et al.

JAMA PEDIATRICS (2013)